| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.08 |